Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid Injection for Oral Pyogenic Granuloma
NCT05534334Phase 3Unknown
- Sponsor
- Beni Suef University
- Start
- May 2022
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocortisone sodium succinate in lobular capillary hemangioma (PG), sponsored by Beni Suef University. Status: unknown.
02
Drugs
hydrocortisone sodium succinate
03
Conditions
lobular capillary hemangioma (PG)
Beyond the preview
Go deeper on NCT05534334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05534334.